Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
about
Development of vaccines to Mycobacterium avium subsp. paratuberculosis infectionDevelopment of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infectionImmunity, safety and protection of an Adenovirus 5 prime--Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves.Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines.A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.Subset-Specific Expression of Toll-Like Receptors by Bovine Afferent Lymph Dendritic Cells.Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.Clinical applications of attenuated MVA poxvirus strain.Vaccinia virus encodes a novel inhibitor of apoptosis that associates with the apoptosome.Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses.Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway.Bovine γδ T cells are a major regulatory T cell subset.Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination.Virulent poxviruses inhibit DNA sensing by preventing STING activation.Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
P2860
Q26739197-4FC55F84-1783-4B79-BD74-B95B3D98B8CAQ27321985-58BE6ABB-4BF1-400E-B96A-6DC597449A91Q34643320-EF302BED-4497-457F-92BA-4F5AA61D20CEQ35641132-A46AF298-D673-43CF-9B9E-B9324FB0A066Q36980878-C2966F8D-8F19-461A-B142-A9AEF1BFD021Q37153663-7ADC0C00-0F12-4AE3-BD57-10DC6F045661Q37656908-69D6FB30-4A28-4072-9E9C-B87B5479AA90Q37733758-50E235DB-D4AF-4A7D-A0CE-9C9B57327C96Q38096490-B0B43C89-0A5F-4E48-9F47-4715B7222BBFQ38156198-909E5910-65ED-4F96-A424-FAEA609EFA74Q40042412-04B50D9E-D2BB-4581-91A6-9E10996AD3DDQ40259625-F9F4646C-FA4F-45DE-80A4-FD6964260BAFQ40574579-192FD2D8-5918-4BA2-838D-58A1504EFD71Q40963680-107182CE-A3FC-4E57-9D8F-D78B5794D932Q50329180-984068CC-A42D-4A9F-972B-DB68CB074E2CQ52680807-55A907A7-9466-4B75-8273-46186B746CD4Q55001866-3530BC49-5326-4D42-A191-19804CCAC69F
P2860
Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Modified vaccinia virus Ankara ...... fficient antigen presentation.
@ast
Modified vaccinia virus Ankara ...... fficient antigen presentation.
@en
type
label
Modified vaccinia virus Ankara ...... fficient antigen presentation.
@ast
Modified vaccinia virus Ankara ...... fficient antigen presentation.
@en
prefLabel
Modified vaccinia virus Ankara ...... fficient antigen presentation.
@ast
Modified vaccinia virus Ankara ...... fficient antigen presentation.
@en
P2860
P50
P356
P1433
P1476
Modified vaccinia virus Ankara ...... efficient antigen presentation
@en
P2093
C Cubillos-Zapata
H Prentice
P2860
P304
P356
10.1128/JVI.00264-12
P407
P577
2012-03-14T00:00:00Z